Survival impact of integrative cancer care in advanced metastatic breast cancer

Breast Journal

Volumn 15, Issue 4, 2009, Pages 357-366

  Block, Keith I ^a,b,c   Gyllenhaal, Charlotte ^a,b   Tripathy, Debu ^d   Freels, Sally ^b   Mead, Mark N ^a   Block, Penny B ^a   Steinmann, William C ^e   Newman, Robert A ^f   Shoham, Jacob ^g,h  

^a Block Center for Integrative Cancer Treatment   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g BAR ILAN UNIVERSITY   (Israel)

^h Israel Center for Health Promoting Therapies   (Israel)

Author keywords

Breast cancer; Chemotherapy; Integrative medicine; Metastatic; Nutrition

Indexed keywords

NUTRACEUTICAL; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; DIET SUPPLEMENTATION; EXERCISE; FEMALE; HISTOPATHOLOGY; HUMAN; INTEGRATIVE MEDICINE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; METASTASIS; MULTIMODALITY CANCER THERAPY; NUTRITION; ONSET AGE; PARTIAL MASTECTOMY; PATIENT CARE; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NUTRITION ASSESSMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 67650760406     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00739.x     Document Type: Article

References (47)

1. Stockler M, Wilcken NR, Ghersi D, et al. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000 26 : 151 68.
2. Fossati R, Confalonieri C, Torri V, et al. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 1998 16 : 3439 60.
3. Bergh J, Jonsson PE, Glimelius B, et al. A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 2001 40 : 258 81.
4. O'Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist 2005 10 (suppl 3 20 9.
5. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001 344 : 783 92.
6. VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 1999 5 : 71 6.
7. Risberg T, Vickers A, Bremnes RM, et al. Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003 39 : 372 7.
8. Saxton JM, Daley A, Woodroofe N, et al. Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231]. BMC Cancer 2006 6 : 35.
9. Verhoef MJ, Lewith G, Ritenbaugh C, et al. Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complement Ther Med 2005 13 : 206 12.
10. Verhoef MJ, Vanderheyden LC, Fønnebø V. A whole systems research approach to cancer care: why do we need it and how do we get started? Integr Cancer Ther 2006 5 : 287 92.
11. Helft PR. Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol 2005 23 : 3146 50.
12. Block KI, Bugno TJ, Collichio FA, et al. Breaking bad news. Integr Cancer Ther 2003 00 : 239 62.
13. Block KI. Dietary impact on quality and quantity of life in cancer patients. In : Quillin P, Williams RM, eds. Adjuvant Nutrition in Cancer Treatment. Arlington Heights, IL : Cancer Treatment Research Foundation/American College of Nutrition, 2003 : 99 127.
14. Block KI. Nutritional oncology and complementary medicine. In : Jonas WB, Levin JS, eds. Essentials of Complementary and Alternative Medicine. Baltimore MD : Lippincott, Williams & Wilkins, Baltimore MD, 1999 : 490 515.
15. Block KI, Koch A, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007 33 : 407 18.
16. Demark-Wahnefried W, Hars V, Conaway MR, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 1997 65 : 1495 501.
17. Dimeo F, Fetscher S, Lange W, et al. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high dose chemotherapy. Blood 1997 90 : 3390 4.
18. Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 2001 93 : 810 23.
19. Block KI. The role of the self in healthy cancer survivorship: a view from the front lines of treating cancer. Advances 1997 13 : 6 26. (Pubitemid 127736560)
20. Richardson MA, Russell NC, Sanders T, et al. Assessment of outcomes at alternative medicine cancer clinics: a feasibility study. J Altern Complement Med 2001 7 : 19 32. (Pubitemid 32181411)
21. Clark GM, Sledge GW Jr, Osborne CK, et al. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987 5 : 55 61. (Pubitemid 17007856)
22. Anderson WF, Reeves JE, Elias A, et al. Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic. Cancer 2000 88 : 95 107. (Pubitemid 30027684)
23. Alba E, Ribelles N, Sevilla I, et al. Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer. Breast Cancer Res Treat 2001 66 : 33 9.
24. Schairer C, Mink PJ, Carroll L, et al. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004 96 : 11311 21.
25. Jayasinghe UW, Taylor R, Boyages J. Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg 2005 75 : 762 7.
26. Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer 2004 100 : 44 52.
27. Sant M, Allemani C, Berrino F, et al. Breast carcinoma survival in Europe and the United States. Cancer 2004 100 : 715 22.
28. Chia SK, Speers CH, D'yachkova Y., et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007 110 : 973 9.
29. Spiegel D, Bloom JR, Kraemer HC, et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989 2 : 888 91.
30. Spiegel D, Butler LD, Glese-Davis J, et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer. A randomized trial. Cancer 2007 110 : 1130 7.
31. McMillan JH. Randomized field trials and internal validity. Not so fast, my friend. Pract Assess Res & Eval 2007 12. Available online: http://pareonline.net/getvn.asp?v=12&n=15.
32. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007 25 : 2345 51.
33. Chlebowski RT, Blackburn GL, Thompson CA, et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006 98 : 1767 76.
34. McCarty MF. Current prospects for controlling cancer growth with non-cytotoxic agents - nutrients, phytochemicals, herbal extracts and available drugs. Med Hypotheses 2001 56 : 137 54.
35. Holmes MD, Chen WY, Feskanich D, et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005 293 : 2479 86.
36. Carlson LE, Speca M, Patel KE, et al. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004 29 : 448 74.
37. Hebert JR, Hurley TG, Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat 1998 51 : 17 28. (Pubitemid 28550157)
38. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002 20 : 3302 16.
39. Stoll B. Can supplementary dietary fibre suppress breast cancer growth? Br J Cancer 1996 73 : 557 9.
40. Bougnoux P, Germain E, Chajes V, et al. Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 1999 79 : 1765 9.
41. Rock CL, Flatt SW, Natarajan L, et al. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol 2005 23 : 6631 8.
42. Yeh CC, Hou MF, Tsai SM, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 2005 361 : 104 11.
43. Lithgow D, Covington C. Chronic inflammation and breast pathology: a theoretical model. Biol Res Nurs 2005 7 : 118 29.
44. Boyd DB. Insulin and cancer. Integr Cancer Ther 2003 2 : 315 29.
45. Barber MD. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 2002 17 : 203 9.
46. Conklin KA. Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther 2005 4 : 110 30.
47. Yang P, Chan D, Felix E, et al. Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 2004 45 : 1030 9.